GEMCITABINE, OXALIPLATIN AND CAPECITABINE (GEMOXEL) FOR PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA (APC). PRELIMINARY RESULTS OF AN ONGOING PHASE I/II TRIAL

被引：0
|
作者：
Hess, V. [1 ]
Pestalozzi, B. [2 ]
Ludwig, C. [3 ]
Winterhalder, R. [4 ]
Lohri, A. [5 ]
Jost, L. [6 ]
Widmer, L. [7 ]
Lee, L. [1 ]
Stillhart, P. [1 ]
Herrmann, R. [1 ]
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] St Clara Hosp, Basel, Switzerland
[4] Kantonsspital Luzern, Luzern, Switzerland
[5] Kantonsspital Liestal, CH-4410 Liestal, Switzerland
[6] Kantonsspital Bruderholz, Bruderholz, Switzerland
[7] Onkozentrum Hirslanden, Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [21] The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study
    Watkins, D. J.
    Starling, N.
    Cunningham, D.
    Thomas, J.
    Webb, J.
    Brown, G.
    Barbachano, Y.
    Oates, J.
    Chau, I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (08) : 1422 - 1429
  • [22] Phase I/II trial of Gemcitabine and Epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A
    Jakobs, R
    Martin, WR
    Riemann, JF
    GASTROENTEROLOGY, 2002, 122 (04) : A493 - A493
  • [23] Phase I/II trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A
    Jakobs, R
    Martin, WR
    Eickhoff, JC
    Riemann, JF
    GASTROENTEROLOGY, 2005, 128 (04) : A432 - A432
  • [24] Bevacizumab in combination with gemcitabine and capecitabine improves quality of life in patients with advanced pancreatic cancer (APC) - final results of the multicenter phase II study
    Javle, M.
    Yu, J.
    Pande, A.
    Garrett, C.
    Kuvshinoff, B.
    Litwin, A.
    Gibbs, J.
    Iyer, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 67 - 67
  • [25] Multi-institutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, followed by Radiotherapy with Concurrent Capecitabine, and Cetuximab, for Locally Advanced Pancreatic Adenocarcinoma (LAPC)
    Crane, C. H.
    Varadhachary, G.
    Javle, M.
    Safran, H.
    Krishnan, S.
    Fleming, J.
    Das, P.
    Lee, J.
    Abbruzzese, J. L.
    Wolff, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S102 - S102
  • [26] Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial
    Markussen, Alice
    Jensen, Lars Henrik
    Diness, Laura Vittrup
    Larsen, Finn Ole
    CANCERS, 2020, 12 (07) : 1 - 10
  • [27] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: final results
    Michael, M.
    Price, T.
    Leong, T.
    Ganju, V.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 272 - 272
  • [28] A randomized phase II trial of PEXG (cisplatin, epirubicin, capecitabine, gemcitabine) or PDXG (docetaxel) regimen in advanced pancreatic adenocarcinoma
    Reni, M.
    Cereda, S.
    Passoni, P.
    Rognone, A.
    Mazza, E.
    Nicoletti, R.
    Arcidiacono, P. G.
    Zerbi, A.
    Balzano, G.
    Di Carlo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: interim results
    Leong, T.
    Michael, M.
    Ganju, V.
    Price, T.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Zalcberg, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 222 - 222
  • [30] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metastatic or recurrent pancreatic cancer
    Sym, Sun Jin
    Hong, Junsik
    Jung, Minkyu
    Koo, Yang Seo
    Park, Yeon Ho
    Kim, Koen Kook
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dongbok
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345